A Post-marketing, Observational Safety Study of Quinsair (Levofloxacin Hemihydrate) in Patients with Cystic Fibrosis [CLI-LEVFLAA1-01] First published 20/09/2017 Last updated 15/01/2025 EU PAS number:EUPAS20990 Study Ongoing